IL-2 regulates SEB induced toxic shock syndrome in BALB/c mice

PLoS ONE

Volumn 4, Issue 12, 2009, Pages

  Khan, Aslam Ali ^a   Priya, Shilpee ^b   Saha, Bhaskar ^b  

^a WASHINGTON UNIVERSITY   (United States)

^b NATIONAL CENTRE FOR CELL SCIENCE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MITOGEN ACTIVATED PROTEIN KINASE P38; STAPHYLOCOCCUS ENTEROTOXIN B; TUMOR NECROSIS FACTOR ALPHA; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ENTEROTOXIN; ENTEROTOXIN B, STAPHYLOCOCCAL; IMIDAZOLE DERIVATIVE; INTERLEUKIN 2; PROTEIN KINASE INHIBITOR; PYRIDINE DERIVATIVE; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BAGG ALBINO MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNOREGULATION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PROTEIN PHOSPHORYLATION; TOXIC SHOCK SYNDROME; ANIMAL; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DISEASE PREDISPOSITION; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; PHOSPHORYLATION; SEPTIC SHOCK; T LYMPHOCYTE;

MUS; STAPHYLOCOCCUS AUREUS;

ANIMALS; DISEASE SUSCEPTIBILITY; ENTEROTOXINS; ENZYME ACTIVATION; IMIDAZOLES; INTERFERON-GAMMA; INTERLEUKIN-12; INTERLEUKIN-2; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PYRIDINES; RECOMBINANT PROTEINS; SHOCK, SEPTIC; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77949512464     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008473     Document Type: Article

References (25)

1. Schrock CG (1980) Disease alert. JAMA 243: 1231.
2. Acharya KR, Passalacqua EF, Jones EY, Harlos K, Stuart DI, et al. (1994) Structural basis of superantigen action inferred from crystal structure of toxic-shock syndrome toxin-1. Nature 367: 94-97.
3. Papageorgiou AC, Acharya KR (2000) Microbial superantigens: from structure to function. Trends Microbiol 8: 369-375.
4. Saha B, Harlan DM, Lee KP, June CH, Abe R (1996) Protection against lethal toxic shock by targeted disruption of the CD28 gene. J Exp Med 183: 2675-2680.
5. Lee VT, Chang AH, Chow AW (1992) Detection of staphylococcal enterotoxin B among toxic shock syndrome (TSS)- and non-TSS-associated Staphylococcus aureus isolates. J Infect Dis 166: 911-915.
6. Herman A, Kappler JW, Marrack P, Pullen AM (1991) Superantigens: mechanism of T-cell stimulation and role in immune responses. Annu Rev Immunol 9: 745-772.
7. Davison S, Allen M, Harmer A, Vaughan R, Barker JN (1999) Increased T-cell receptor vbeta2 chain expression in skin homing lymphocytes in psoriasis. Br J Dermatol 140: 845-848.
8. Kotzin BL, Leung DY, Kappler J, Marrack P (1993) Superantigens and their potential role in human disease. Adv Immunol 54: 99-166.
9. Miethke T, Wahl C, Regele D, Gaus H, Heeg K, et al. (1993) Superantigen mediated shock: a cytokine release syndrome. Immunobiology 189: 270-284.
10. Neumann B, Engelhardt B, Wagner H, Holzmann B (1997) Induction of acute inflammatory lung injury by staphylococcal enterotoxin B. J Immunol 158: 1862-1871.
11. Miethke T, Wahl C, Heeg K, Echtenacher B, Krammer PH, et al. (1992) T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J Exp Med 175: 91-98.
12. Smith KA (1988) Interleukin-2: inception, impact, and implications. Science 240: 1169-1176.
13. Aicher A, Shu GL, Magaletti D, Mulvania T, Pezzutto A, et al. (1999) Differential role for p38 mitogen-activated protein kinase in regulating CD40-induced gene expression in dendritic cells and B cells. J Immunol 163: 5786-5795.
14. Andreae S, Buisson S, Triebel F (2003) MHC class II signal transduction in human dendritic cells induced by a natural ligand, the LAG-3 protein (CD223). Blood 102: 2130-2137.
15. Khan AA, Martin S, Saha B (2008) SEB-induced signaling in macrophages leads to biphasic TNF-alpha. J Leukoc Biol 83: 1363-1369.
16. ten Hove T, van den Blink B, Pronk I, Drillenburg P, Peppelenbosch MP, et al. (2002) Dichotomal role of inhibition of p38 MAPK with SB 203580 in experimental colitis. Gut 50: 507-512.
17. Baxter AG, Hodgkin PD (2002) Activation rules: the two-signal theories of immune activation. Nat Rev Immunol 2: 439-446.
18. Car BD, Eng VM, Schnyder B, Ozmen L, Huang S, et al. (1994) Interferon gamma receptor deficient mice are resistant to endotoxic shock. J Exp Med 179: 1437-1444.
19. Bachmann MF, Schorle H, Kuhn R, Muller W, Hengartner H, et al. (1995) Antiviral immune responses in mice deficient for both interleukin-2 and interleukin-4. J Virol 69: 4842-4846.
20. Matsuda Y, Kato H, Yamada R, Okano H, Ohta H, et al. (2003) Early and definitive diagnosis of toxic shock syndrome by detection of marked expansion of T-cell-receptor VBeta2-positive T cells. Emerg Infect Dis 9: 387-389.
21. Lagoo AS, Lagoo-Deenadayalan S, Lorenz HM, Byrne J, Barber WH, et al. (1994) IL-2, IL-4, and IFN-gamma gene expression versus secretion in superantigen-activated T cells. Distinct requirement for costimulatory signals through adhesion molecules. J Immunol 152: 1641-1652.
22. Burns LJ, Weisdorf DJ, DeFor TE, Vesole DH, Repka TL, et al. (2003) IL-2- based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial. Bone Marrow Transplant 32: 177-186.
23. Batten M, Fletcher C, Ng LG, Groom J, Wheway J, et al. (2004) TNF deficiency fails to protect BAFF transgenic mice against autoimmunity and reveals a predisposition to B cell lymphoma. J Immunol 172: 812-822.
24. Aboud-Pirak E, Lubin I, Pirak ME, Canaan A, Lowell GH, et al. (1995) Lethally irradiated normal strains of mice radioprotected with SCID bone marrow develop sensitivity to low doses of staphylococcal enterotoxin B. Immunol Lett 46: 9-14.
25. Trizio D, Cudkowicz G (1974) Separation of T and B lymphocytes by nylon wool columns: evaluation of efficacy by functional assays in vivo. J Immunol 113: 1093-1097.